Tapewire

Nasdaq · USD

KIDS

ORTHOPEDIATRICS CORP

Export transactions ↓
Tapewire entity
5338
SEC CIK
0001425450
Parsed reports
303

Last 12 months

Inside the activity.

0 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202605
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026012
Sep 202609
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 16, 2017 Filed Oct 16, 2017 22:04 UTC
Bailey David RExecutive Vice President
Tax withholdingCommon Stock 14,835 $13.00 $192,855.00
Disclosure

SEC source: 0001144204-17-052684 · tv477017_4.xml · nonDerivative · entry 2

Bailey David R · CIK 0001719296 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,998

F2 · shares: Represents shares delivered to the Issuer to satisfy tax withholdings in connection with the lapse of restrictions on 32,117 shares of restricted common stock.

Read SEC document
October 16, 2017 Filed Oct 16, 2017 22:04 UTC
Bailey David RExecutive Vice President
GrantCommon Stock 3,685 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-052684 · tv477017_4.xml · nonDerivative · entry 1

Bailey David R · CIK 0001719296 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,833

F1 · shares: Represents shares of restricted stock granted pursuant to the Issuer's 2017 Incentive Award Plan. These shares will vest in full on the six month anniversary of the grant date (subject to the reporting person's continued service through such date); provided, however, that these shares will vest in full if the reporting person's employment is terminated by reason of death or disability or without "cause," or if the reporting person terminates his employment for "good reason" (each as defined in the reporting person's employment agreement).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.